We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACA icon
1901
Arcosa
ACA
$7.12B
-6,265
Closed -$276K
ACI icon
1902
Albertsons Companies
ACI
$6.01B
-38,564
Closed -$534K
ACIU icon
1903
AC Immune
ACIU
$288M
-16,100
Closed -$79K
ACLS icon
1904
Axcelis
ACLS
$3.92B
-9,343
Closed -$206K
ADCT icon
1905
ADC Therapeutics
ADCT
$127M
-81,624
Closed -$2.69M
ZNB
1906
Zeta Network Group
ZNB
$1.72M
0
-$67K
ADEA icon
1907
Adeia
ADEA
$2.89B
-95,596
Closed -$291K
ADPT icon
1908
CALL
Adaptive Biotechnologies
ADPT
$4.15B
-15,100
Closed -$734K
AER icon
1909
AerCap
AER
$23B
-25,415
Closed -$640K
AFG icon
1910
American Financial Group
AFG
$11.9B
-226,074
Closed -$15.1M
AGNC icon
1911
AGNC Investment
AGNC
$12.9B
-18,488
Closed -$257K
AGO icon
1912
Assured Guaranty
AGO
$3.27B
-224,887
Closed -$4.83M
AIN icon
1913
Albany International
AIN
$1.68B
-12,629
Closed -$625K
AIR icon
1914
AAR Corp
AIR
$5.43B
-10,004
Closed -$188K
AIT icon
1915
Applied Industrial Technologies
AIT
$12.5B
-7,773
Closed -$428K
AIV
1916
Aimco
AIV
$381M
-111,934
Closed -$503K
AJG icon
1917
Arthur J. Gallagher & Co
AJG
$67.6B
-16,274
Closed -$1.72M
AKR icon
1918
Acadia Realty Trust
AKR
$2.89B
-68,277
Closed -$717K
ALB icon
1919
Albemarle
ALB
$16.9B
-44,665
Closed -$3.99M
ALE
1920
DELISTED
Allete
ALE
-5,674
Closed -$294K
ALGT icon
1921
Allegiant Air
ALGT
$2.24B
-18,093
Closed -$2.17M
ALLE icon
1922
Allegion
ALLE
$13.8B
-9,885
Closed -$978K
ALRM icon
1923
Alarm.com
ALRM
$2.82B
-7,669
Closed -$424K
AMC icon
1924
AMC Entertainment Holdings
AMC
$2.28B
-3,634
Closed -$171K
AMED
1925
DELISTED
Amedisys
AMED
-1,292
Closed -$305K

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.